A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma
Laura Rosiñol(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Joan Bladé(Hospital Clínic de Barcelona), Juan José Lahuerta(Research Institute Hospital 12 de Octubre), Jesús F. San Miguel(Clinica Universidad de Navarra), Javier de la Rubia(Universitat de València), Belén Hernández(Hospital General Universitario de Ciudad Real), Miguel‐Teodoro Hernández(Hospital Universitario de Canarias), Juan Bergua(Hospital San Pedro de Alcántara), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Javier García‐Frade(Centro de Investigación del Cáncer), Josè Antonio Pérez-Simón(Instituto de Biomedicina de Sevilla), José D. González(Hospital Universitario Insular de Gran Canaria), Ángel León(Hospital Jerez Puerta del Sur), Joaquín Diaz‐Mediavilla(Hospital Clínico San Carlos), Dolores Carrera(Hospital Universitario Central de Asturias), Felipe de Arriba(Hospital General Universitario Morales Meseguer)
Cited by 264
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k